BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Pinxteren B, Sigterman KE, Bonis P, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2010;CD002095. [PMID: 21069670 DOI: 10.1002/14651858.cd002095.pub4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Gutschow CA, Hölscher AH. Surgical treatment of gastroesophageal reflux disease. Langenbecks Arch Surg. 2013;398:661-667. [PMID: 22526414 DOI: 10.1007/s00423-012-0952-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Savarino V, Marabotto E, Zentilin P, Demarzo MG, de Bortoli N, Savarino E. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art. Drug Des Devel Ther 2021;15:1609-21. [PMID: 33907381 DOI: 10.2147/DDDT.S306371] [Reference Citation Analysis]
3 Souza TF, Grecco E, Quadros LG, Albuquerque YD, Azôr FO, Galvão Neto M. SHORT-TERM RESULTS OF MINIMALLY INVASIVE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE BY RADIOFREQUENCY (STRETTA): FIRST BRAZILIAN SERIES OF CASES. Arq Gastroenterol 2018;55Suppl 1:52-5. [PMID: 30517356 DOI: 10.1590/S0004-2803.201800000-51] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ren LH, Chen WX, Qian LJ, Li S, Gu M, Shi RH. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: A meta-analysis. World J Gastroenterol 2014; 20(9): 2412-2419 [PMID: 24605040 DOI: 10.3748/wjg.v20.i9.2412] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
5 Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2013;CD002095. [PMID: 23728637 DOI: 10.1002/14651858.cd002095.pub5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
6 Cho YK, Choi MG, Park H, Kim JW, Lee DH, Ko KH, Kim SG, Jung HY, Hong SJ, Lee YC, Lee SH. Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial. J Neurogastroenterol Motil 2021;27:223-30. [PMID: 33795542 DOI: 10.5056/jnm19053] [Reference Citation Analysis]
7 Jung DH, Huh CW, Lee SK, Park JC, Shin SK, Lee YC. A Systematic Review and Meta-analysis of Randomized Control Trials: Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:165-75. [PMID: 33795539 DOI: 10.5056/jnm20161] [Reference Citation Analysis]
8 Hughes J, Y Y Chiu D, Kalra PA, Green D. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease. PLoS One 2018;13:e0197400. [PMID: 29799851 DOI: 10.1371/journal.pone.0197400] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
9 Lo WK, Goldberg HJ, Boukedes S, Burakoff R, Chan WW. Proton Pump Inhibitors Independently Protect Against Early Allograft Injury or Chronic Rejection After Lung Transplantation. Dig Dis Sci 2018;63:403-10. [PMID: 29094310 DOI: 10.1007/s10620-017-4827-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
10 Cahir C, Fahey T, Tilson L, Teljeur C, Bennett K. Proton pump inhibitors: potential cost reductions by applying prescribing guidelines. BMC Health Serv Res 2012;12:408. [PMID: 23163956 DOI: 10.1186/1472-6963-12-408] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
11 Kandulski A, Peitz U, Mönkemüller K, Neumann H, Weigt J, Malfertheiner P. GERD assessment including pH metry predicts a high response rate to PPI standard therapy. BMC Gastroenterol 2013;13:12. [PMID: 23324360 DOI: 10.1186/1471-230X-13-12] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
12 Sugimoto M, Nishino M, Kodaira C, Yamade M, Uotani T, Ikuma M, Umemura K, Furuta T. Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy. World J Gastroenterol 2011; 17(14): 1858-1865 [PMID: 21528060 DOI: 10.3748/wjg.v17.i14.1858] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;CD001216. [PMID: 17253456 DOI: 10.1002/14651858] [Cited by in Crossref: 2625] [Cited by in F6Publishing: 769] [Article Influence: 175.0] [Reference Citation Analysis]
14 Kim JJ, Jang EJ, Park J, Sohn HS. Association between proton pump inhibitor use and risk of fracture: A population-based case-control study. PLoS One 2020;15:e0235163. [PMID: 32730257 DOI: 10.1371/journal.pone.0235163] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Becker MO. [Systemic sclerosis : What is currently available for treatment?]. Internist (Berl) 2016;57:1155-63. [PMID: 27796473 DOI: 10.1007/s00108-016-0148-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Jung HK, Tae CH, Song KH, Kang SJ, Park JK, Gong EJ, Shin JE, Lim HC, Lee SK, Jung DH, Choi YJ, Seo SI, Kim JS, Lee JM, Kim BJ, Kang SH, Park CH, Choi SC, Kwon JG, Park KS, Park MI, Lee TH, Kim SY, Cho YS, Lee HH, Jung KW, Kim DH, Moon HS, Miwa H, Chen CL, Gonlachanvit S, Ghoshal UC, Wu JCY, Siah KTH, Hou X, Oshima T, Choi MY, Lee KJ; Korean Society of Neurogastroenterology and Motility. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J Neurogastroenterol Motil 2021;27:453-81. [PMID: 34642267 DOI: 10.5056/jnm21077] [Reference Citation Analysis]
17 Lundell L, Bell M, Ruth M. Systematic review: Laparoscopic fundoplication for gastroesophageal reflux disease in partial responders to proton pump inhibitors. World J Gastroenterol 2014; 20(3): 804-813 [PMID: 24574753 DOI: 10.3748/wjg.v20.i3.804] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
18 Pouchain D, Bigard MA, Liard F, Childs M, Decaudin A, McVey D. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial. BMC Gastroenterol 2012;12:18. [PMID: 22361121 DOI: 10.1186/1471-230X-12-18] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
19 Ren LH, Chen WX, Qian LJ, Li S, Gu M, Shi RH. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2014;20:2412-2419. [PMID: 24605040 DOI: org/10.3748/wjg.v20.i9.2412] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy. Gut. 2014;63:720-726. [PMID: 23831734 DOI: 10.1136/gutjnl-2013-304883] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
21 Rogers BD, Gyawali CP. Why differences between New York and New Delhi matter in approach to gastroesophageal reflux disease. Indian J Gastroenterol 2019;38:371-7. [DOI: 10.1007/s12664-019-00987-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Jamshed S, Bhagavathula AS, Zeeshan Qadar SM, Alauddin U, Shamim S, Hasan S. Cost-effective Analysis of Proton Pump Inhibitors in Long-term Management of Gastroesophageal Reflux Disease: A Narrative Review. Hosp Pharm 2020;55:292-305. [PMID: 32999499 DOI: 10.1177/0018578719893378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Pratha VS, McGraw T, Tobin W. A randomized, crossover pharmacodynamic study of immediate-release omeprazole/sodium bicarbonate and delayed-release lansoprazole in healthy adult volunteers. Pharmacol Res Perspect 2016;4:e00238. [PMID: 27433347 DOI: 10.1002/prp2.238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Wang YK, Hsu WH, Wang SS, Lu CY, Kuo FC, Su YC, Yang SF, Chen CY, Wu DC, Kuo CH. Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract 2013;2013:983653. [PMID: 23878534 DOI: 10.1155/2013/983653] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
25 Mousa H, Hassan M. Gastroesophageal Reflux Disease. Pediatr Clin North Am 2017;64:487-505. [PMID: 28502434 DOI: 10.1016/j.pcl.2017.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 Gawron AJ, Pandolfino JE. Ambulatory reflux monitoring in GERD--which test should be performed and should therapy be stopped? Curr Gastroenterol Rep 2013;15:316. [PMID: 23475599 DOI: 10.1007/s11894-013-0316-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
27 Gold BD, Pilmer B, Kierkuś J, Hunt B, Perez MC, Gremse D. Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease. Dig Dis Sci 2017;62:3059-68. [PMID: 28916953 DOI: 10.1007/s10620-017-4743-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Franciosa M, Triadafilopoulos G, Mashimo H. Stretta Radiofrequency Treatment for GERD: A Safe and Effective Modality. Gastroenterol Res Pract. 2013;2013:783815. [PMID: 24078808 DOI: 10.1155/2013/783815] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]